Examination of Left Atrial Fibrosis Using MRI

This study is enrolling participants by invitation only.
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
First received: November 2, 2010
Last updated: November 21, 2011
Last verified: November 2011
This study evaluates images obtained from a standard clinical cardiac MRI for evidence of fibrosis.


Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Examination of Left Atrial Fibrosis Using MRI

Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 100
Study Start Date: March 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
patients referred for standard of care MRI


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients referred for standard of care MRI

Inclusion Criteria:

  • 18+ years of age
  • being scheduled for a standard of care MRI

Exclusion Criteria:

- patient unable to provide informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01233674

United States, Pennsylvania
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01233674     History of Changes
Other Study ID Numbers: 08120067
Study First Received: November 2, 2010
Last Updated: November 21, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on November 27, 2015